Favipiravir, maribavir and venetoclax have been added to the interaction checker as comedications.
- Favipiravir is an antiviral originally approved in Japan for the treatment of influenza but is now being investigated for the treatment of COVID-19.
- Maribavir is an antiviral indicated for the treatment of cytomegalovirus (CMV) infection in transplant patients.
- Venetoclax is a cancer therapy used to treat chronic lymphocytic leukaemia (CLL), small lymphocytic lymphoma (SLL) or acute myeloid leukaemia (AML).
